secwatch / observer
8-K filed June 14, 2023, 7:59 PM ET ticker VC CIK 0001111335
other confidence high sentiment neutral materiality 0.10

Visteon annual meeting: all director nominees elected, auditor ratified, say-on-pay approved, chairman reappointed

VISTEON CORP

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

VISTEON CORP shareholders approved Election of directors (majority voting) at the 2023-06-08 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-08
Exact text from the filing
The final voting results are set forth below. (1) Election of directors (majority voting): Nominee Shares For Shares Against Shares Abstain Broker Non-Votes James J. Barrese 25,141,854 580,050 26,882 705,324
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

VISTEON CORP shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2023 at the 2023-06-08 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-08
Exact text from the filing
Ratification of the appointment of Deloitte & Touche LLP: Shares For Shares Against Shares Abstain Broker Non-Votes 25,427,308 1,012,596 14,206 N/A
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

VISTEON CORP shareholders approved Advisory approval of the Company’s executive compensation at the 2023-06-08 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-06-08
Exact text from the filing
Provide advisory approval of the Company’s executive compensation: Shares For Shares Against Shares Abstain Broker Non-Votes 25,089,679 647,817 11,290 705,324
View on SEC.gov

Browse all shareholder votes →

VISTEON CORP filing history →

Source: SEC EDGAR
accession 0001111335-23-000034
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.